申请人:Molecular Insight Pharmaceuticals, Inc.
公开号:US20140179902A1
公开(公告)日:2014-06-26
Complexes of heterocyclic radionuclides are prepared based upon ligands having substituted pyridyl and imidazolyl groups. The ligands are bifunctional, having amino acid residues that may act as a linker to a bioactive molecule, and a tridentate chelator that may complex the radionuclide. The bioactive molecule may be a peptide or somatostatin.
基于具有取代
吡啶和
咪唑基团的
配体制备了杂环放射性核素的配合物。这些
配体是双功能的,具有
氨基酸残基,可以作为与
生物活性分子连接器的作用,以及三齿
螯合剂,可以与放射性核素形成配合物。
生物活性分子可以是肽或
生长抑素。